233 related articles for article (PubMed ID: 11567908)
1. [Oxaliplatin: a first DACH-platinum in oncology].
Laadem A; Cvitkovic E
Bull Cancer; 2001 Aug; 88 Spec No():S9-13. PubMed ID: 11567908
[TBL] [Abstract][Full Text] [Related]
2. [Oxaliplatin: the first DACH platinum in clinical practice].
Soulié P; Raymond E; Brienza S; Cvitkovic E
Bull Cancer; 1997 Jun; 84(6):665-73. PubMed ID: 9295871
[TBL] [Abstract][Full Text] [Related]
3. Review of oxaliplatin: an active platinum agent in colorectal cancer.
Cassidy J
Int J Clin Pract; 2000; 54(6):399-402. PubMed ID: 11092115
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin: a review of preclinical and clinical studies.
Raymond E; Chaney SG; Taamma A; Cvitkovic E
Ann Oncol; 1998 Oct; 9(10):1053-71. PubMed ID: 9834817
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
Culy CR; Clemett D; Wiseman LR
Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
[TBL] [Abstract][Full Text] [Related]
6. [Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer].
André T; Louvet C; Maindrault-Goebel F; Gramont AD
Bull Cancer; 2001 Aug; 88 Spec No():S20-5. PubMed ID: 11567910
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin (L-OHP): a new reality in colorectal cancer.
Bleiberg H
Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):1-3. PubMed ID: 9647611
[TBL] [Abstract][Full Text] [Related]
8. Platinum compounds in the treatment of advanced breast cancer.
Martín M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
9. Current status of oxaliplatin in colorectal cancer.
O'Dwyer PJ; Johnson SW
Semin Oncol; 2003 Jun; 30(3 Suppl 6):78-87. PubMed ID: 12802798
[TBL] [Abstract][Full Text] [Related]
10. Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis.
Landre T; Uzzan B; Nicolas P; Aparicio T; Zelek L; Mary F; Taleb C; Des Guetz G
Int J Colorectal Dis; 2015 Oct; 30(10):1305-10. PubMed ID: 26099322
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin: mechanism of action and antineoplastic activity.
Raymond E; Faivre S; Woynarowski JM; Chaney SG
Semin Oncol; 1998 Apr; 25(2 Suppl 5):4-12. PubMed ID: 9609103
[TBL] [Abstract][Full Text] [Related]
12. [Oxaliplatin].
Furue H
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1195-202. PubMed ID: 16121929
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin: a new therapeutic option in colorectal cancer.
Cvitkovic E; Bekradda M
Semin Oncol; 1999 Dec; 26(6):647-62. PubMed ID: 10606258
[TBL] [Abstract][Full Text] [Related]
14. Ongoing and unsaid on oxaliplatin: the hope.
Cvitkovic E
Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):8-11. PubMed ID: 9647613
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
Berg D
Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin in practice.
Misset JL
Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):4-7. PubMed ID: 9647612
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin: pharmacokinetics and chronopharmacological aspects.
Lévi F; Metzger G; Massari C; Milano G
Clin Pharmacokinet; 2000 Jan; 38(1):1-21. PubMed ID: 10668856
[TBL] [Abstract][Full Text] [Related]
18. Safety of oxaliplatin in the treatment of colorectal cancer.
Haller DG
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):15-20. PubMed ID: 11204657
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oxaliplatin in the treatment of colorectal cancer.
Rothenberg ML
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):9-14. PubMed ID: 11204666
[TBL] [Abstract][Full Text] [Related]
20. A review of oxaliplatin and its clinical use in colorectal cancer.
Grothey A; Goldberg RM
Expert Opin Pharmacother; 2004 Oct; 5(10):2159-70. PubMed ID: 15461551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
